June 11, 2025: Wockhardt Ltd, a midcap player in the pharmaceuticals sector, made headlines on Wednesday with a spectacular intraday surge of 14.84%, pushing its share price to ₹1781.15, well above its previous 52-week high of ₹1678.60. The stock saw high volatility, ranging between ₹1546.55 and ₹1788, before closing near its intraday peak.
Also Read: Trident Stock Hits New Highs Today: What Traders Need to Know
This remarkable gain comes on the back of strong market momentum and renewed investor interest in pharmaceutical stocks, particularly in high-growth midcaps.
📈 Performance Overview
Wockhardt has been on a steep upward trajectory:
| Time Period | Return (%) |
|---|---|
| 1 Day | +14.84 |
| 1 Week | +12.16 |
| 1 Month | +39.83 |
| 3 Months | +38.19 |
| 6 Months | +17.42 |
| 1 Year | +185.81 |
| 3 Years | +609.02 |
| 5 Years | +587.91 |
The pharma company’s 1-year return of 185.81% and 3-year return of over 600% place it among the top-performing stocks in its category.
🧪 Technical Analysis & Moving Averages
The stock’s daily pivot level is pegged at ₹1561.05, suggesting strong technical support at lower levels. Key resistance and support levels are as follows:
- Resistance: R1 ₹1567.15 | R2 ₹1576.10 | R3 ₹1582.20
- Support: S1 ₹1552.10 | S2 ₹1546.00 | S3 ₹1537.05
Moving Averages (SMA & EMA)
| Duration | SMA (₹) | EMA (₹) |
|---|---|---|
| 5-Day | 1505.55 | 1513.10 |
| 10-Day | 1449.88 | 1475.43 |
| 20-Day | 1383.27 | 1425.61 |
| 50-Day | 1363.14 | 1382.35 |
| 100-Day | 1370.30 | 1351.67 |
| 200-Day | 1280.63 | 1236.01 |
The stock is now trading well above all major moving averages, reinforcing a strong bullish trend with continued momentum potential.
🏥 Sector Comparison: Wockhardt vs Sun Pharma
| Metric | Wockhardt | Sun Pharma |
|---|---|---|
| 1 Week (%) | +12.16 | +1.19 |
| 1 Month (%) | +31.72 | -0.07 |
| 3 Months (%) | +30.18 | +1.77 |
| 6 Months (%) | +17.42 | -7.15 |
| 1 Year (%) | +185.81 | +12.37 |
| 3 Years (%) | +609.02 | +103.16 |
| 5 Years (%) | +587.91 | +255.79 |
While Sun Pharma remains a large-cap giant, Wockhardt’s superior returns across all time frames highlight its aggressive growth trajectory and growing investor interest.
🔍 Investor Takeaway
With the stock now hovering near its all-time highs, analysts caution that while momentum is strong, profit-booking could set in if market sentiment shifts. However, the underlying fundamentals and sector tailwinds may support continued upside if pharma demand and exports hold steady.
Wockhardt’s performance reflects both technical strength and long-term bullish sentiment, making it a stock to watch closely in the coming weeks.